The Effect of Structured Transition Care Model Applied to Adolescents With Congenital Heart Disease

Recruiting N/A Interventional Study
Congenital Heart Disease in Adolescence
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
16 – 20
Sex
Any
Study type
Interventional
Purpose
Other
Participants needed
70 (estimated)
Sponsor
Ankara Yildirim Beyazıt University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Congenital heart disease is one of the most common congenital defects with a high mortality and morbidity rate. Children with congenital heart disease step from pediatric care to adult care during adolescence. This situation has brought up transitional care, which is defined as "the purposeful and planned movement of adolescents and young adults with chronic physical and medical conditions from pe…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Voluntarily agree to participate in the research * To be between the ages of 16-20, * Having a diagnosis of congenital heart disease, * Being followed up with a diagnosis of congenital heart disease for at least one year in the polyclinics where the study was conducted, * To b…
Contacts

Tutku KIRÇI TEMİZ, PhD s.

+905064278982

tutkukrc29095@gmail.com

CONTACT

Utku ARMAN ÖRÜN, Prof.Dr.

+905322933072

utkuarman.orun@sbu.edu.tr

CONTACT